Psychedelic Library

NUMINOUS adj. /ˈnuːmɪnəs/ A term derived from the Latin numen, meaning "arousing spiritual emotion; mysterious or awe-inspiring."

Numinous Ways Psychedelic Library

We’re building a complete list of books and articles about psychedelics. This includes everything we’ve mentioned in our articles and additional items suggested by our readers.

You can get each item in RIS format for your reference software by clicking the ‘CITE’ link. We like using Zotero. If you know of a title we should add, please let us know through this form. Remember to use APA format and include the DOI identifier when you suggest a title

Bibliography

Aaronson, S. T., van der Vaart, A., Miller, T., LaPratt, J., Swartz, K., Shoultz, A., Lauterbach, M., Sackeim, H. A., & Suppes, T. (2023). Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Controlled Trial. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2023.4685

Barrett, F. S., Preller, K. H., & Kaelen, M. (2018). Psychedelics and music: neuroscience and therapeutic implications. International Review of Psychiatry, 30(4), 350–362. https://doi.org/10.1080/09540261.2018.1484342

Luan, L. X., Eckernäs, E., Ashton, M., Rosas, F. E., Uthaug, M. V., Bartha, A., Jagger, S., Gascon-Perai, K., Gomes, L., Nutt, D. J., Erritzøe, D., Carhart-Harris, R. L., & Timmermann, C. (2023). Psychological and physiological effects of extended DMT. Journal of Psychopharmacology, 02698811231196877. https://doi.org/10.1177/02698811231196877

Gründer, G., Brand, M., Mertens, L. J., Jungaberle, H., Kärtner, L., Scharf, D. J., Spangemacher, M., & Wolff, M. (2023). Treatment with psychedelics is psychotherapy: beyond reductionism. The Lancet Psychiatry, 0(0). https://doi.org/10.1016/S2215-0366(23)00363-2

The Transpersonal: Spirituality in Psychotherapy and Counselling. (n.d.). Routledge & CRC Press. Retrieved November 13, 2023, from https://www.routledge.com/The-Transpersonal-Spirituality-in-Psychotherapy-and-Counselling/Rowan/p/book/9781138881495

The Cosmic Game: Explorations of... by Grof, Stanislav. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Cosmic-Game-Explorations-Consciousness-Transpersonal/dp/0791438767/ref=sr_1_1?crid=10SSGELBX8O9Q&keywords=grof+cosmic&qid=1699840212&s=books&sprefix=grof+cosmic%2Cstripbooks%2C80&sr=1-1

Letheby, C. (2021). Philosophy of Psychedelics. Oxford University Press. https://philarchive.org/rec/LETPOP

The Transpersonal: Spirituality... by Rowan, John. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Transpersonal-John-Rowan/dp/1583919872/ref=sr_1_3?crid=17M4WK9OHWLWV&keywords=rowan+john&qid=1699840354&s=books&sprefix=rowan+john%2Cstripbooks%2C88&sr=1-3

The Transpersonal: Psychotherapy and... by Rowan, John. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Transpersonal-Psychotherapy-Counselling-John-Rowan/dp/0415053625

Otherworlds: Psychedelics and Exceptional Human Experience (Muswell Hill Press) : Luke, David: Amazon.co.uk: Books. (n.d.). Retrieved November 13, 2023, from https://www.amazon.co.uk/Otherworlds-Psychedelics-Exceptional-Experience-Muswell/dp/1908995149

Hoffman, D. D. (2020). The Case Against Reality: How Evolution Hid the Truth from Our Eyes (1st edition). Penguin.

Carhart-Harris, R. L., & Goodwin, G. M. (2017). The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology, 42(11), 2105–2113. https://doi.org/10.1038/npp.2017.84

Maclean, K. A., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2012). Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Journal for the Scientific Study of Religion, 51(4), 721–737. https://doi.org/10.1111/j.1468-5906.2012.01685.x

Self unbound: ego dissolution in psychedelic experience | Neuroscience of Consciousness | Oxford Academic. (n.d.). Retrieved October 6, 2022, from https://academic.oup.com/nc/article/2017/1/nix016/3916730

Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects - Alan K Davis, John M Clifton, Eric G Weaver, Ethan S Hurwitz, Matthew W Johnson, Roland R Griffiths, 2020. (n.d.). Retrieved November 11, 2023, from https://journals.sagepub.com/doi/full/10.1177/0269881120916143

Huxley, A. (2004). The doors of perception and Heaven and hell (1st Perennial Classics ed). Perennial Classics.

Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019). Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century. Journal of Psychoactive Drugs, 51(3), 210–217. https://doi.org/10.1080/02791072.2019.1581961

Holze, F., Ley, L., Müller, F., Becker, A. M., Straumann, I., Vizeli, P., Kuehne, S. S., Roder, M. A., Duthaler, U., Kolaczynska, K. E., Varghese, N., Eckert, A., & Liechti, M. E. (2022). Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology, 47(6), 1180–1187. https://doi.org/10.1038/s41386-022-01297-2

Halberstadt, A. L., & Geyer, M. A. (2011). Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 61(3), 364–381. https://doi.org/10.1016/j.neuropharm.2011.01.017

Carboué, Q., & Lopez, M. (2021). Amanita muscaria: Ecology, chemistry, myths. Encyclopedia, 1(3), 905–914. https://www.mdpi.com/2673-8392/1/3/69

Hastings, A. (2006). An Extended Nondrug MDMA-Like Experience Evoked Through Posthypnotic Suggestion. Journal of Psychoactive Drugs, 38(3), 273–283. https://doi.org/10.1080/02791072.2006.10399853

Castro Santos, H., & Gama Marques, J. (2021). What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review. Porto Biomedical Journal, 6(1), e128. https://doi.org/10.1097/j.pbj.0000000000000128

Reavey, P., Boden, Z., & Anderson, K. (2018). An Affective (Re)balancing Act? The Liminal Possibilities for Heterosexual Partners on MDMA. https://www.researchgate.net/publication/322791658_An_Affective_Rebalancing_Act_The_Liminal_Possibilities_for_Heterosexual_Partners_on_MDMA

Bonson, K. R., & Murphy, D. L. (1995). Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium. Behavioural Brain Research, 73(1), 229–233. https://doi.org/10.1016/0166-4328(96)00102-7

Parry, G. J., & Buenz, E. J. (2018). Adventures in self experimentation. Br Med J, 363, k5006. https://doi.org/10.1136/bmj.k5006

Papaseit, E., Farré, M., Pérez-Mañá, C., Torrens, M., Ventura, M., Pujadas, M., de la Torre, R., & González, D. (2018). Acute Pharmacological Effects of 2C-B in Humans: An Observational Study. Frontiers in Pharmacology, 9(206). https://doi.org/10.3389/fphar.2018.00206

Borissova, A., Ferguson, B., Wall, M. B., Morgan, C. J., Carhart-Harris, R. L., Bolstridge, M., Bloomfield, M. A., Williams, T. M., Feilding, A., Murphy, K., Tyacke, R. J., Erritzoe, D., Stewart, L., Wolff, K., Nutt, D., Curran, H. V., & Lawn, W. (2020). Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. Journal of Psychopharmacology, 0(0), 0269881120926673. https://doi.org/10.1177/0269881120926673

Bouso, J. C., Fabregas, J. M., Antonijoan, R. M., Rodriguez-Fornells, A., & Riba, J. (2013). Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Psychopharmacology (Berl), 230(3), 415–424. https://doi.org/10.1007/s00213-013-3167-9

Zheng, W., Cai, D.-B., Xiang, Y.-Q., Zheng, W., Jiang, W.-L., Sim, K., Ungvari, G. S., Huang, X., Huang, X.-X., Ning, Y.-P., & Xiang, Y.-T. (2020). Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies. Journal of Affective Disorders, 265, 63–70. https://doi.org/10.1016/j.jad.2020.01.002

Michael, P., Luke, D., & Robinson, O. (2021). An Encounter with the Other: A Thematic Analysis of Accounts of DMT Experiences from a Naturalistic Field Study. PsyArXiv. https://doi.org/10.31234/osf.io/8cdgs

Davenport, L. (2021). Adjunctive MDMA safe, effective for severe PTSD. https://www.medscape.com/viewarticle/949243?src=WNL_mdpls_210416_mscpedit_psych&uac=25072MJ&spon=12&impID=3315763&faf=1

Kamboj, S. K., Walldén, Y. S. E., Falconer, C. J., Alotaibi, M. R., Blagbrough, I. S., Husbands, S. M., & Freeman, T. P. (2018). Additive effects of 3,4-Methylenedioxymethamphetamine (MDMA) and compassionate imagery on self-compassion in recreational users of ecstasy. Mindfulness, 9(4), 1134–1145. https://doi.org/10.1007/s12671-017-0849-0

Austin, E., Myron, H. S., Summerbell, R. K., & Mackenzie, C. A. (2019). Acute renal injury cause by confirmed Psilocybe cubensis mushroom ingestion. Medical Mycology Case Reports, 23, 55–57. https://doi.org/10.1016/j.mmcr.2018.12.007

Harwick, R. M., Carlini, B. H., & Garrett, S. B. (2020). A Taxonomy of Consumers’ Perspectives on the Function of Cannabis in Their Lives: A Qualitative Study in WA State, USA. Journal of Psychoactive Drugs, 1–8. https://doi.org/10.1080/02791072.2020.1763522

Ballew, M., & Omoto, A. (2018). Absorption: how nature experiences promote awe and other positive emotions. Ecopsychology, 10(1), 26–35. https://doi.org/10.1089/eco.2017.0044

Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011). Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol, 25(11), 1434–1452. https://doi.org/10.1177/0269881110382466

Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004). Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study. Psychopharmacology, 172(2), 145–156. https://doi.org/10.1007/s00213-003-1640-6

Holze, F., Vizeli, P., Ley, L., Müller, F., Dolder, P., Stocker, M., Duthaler, U., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020). Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology. https://doi.org/10.1038/s41386-020-00883-6

Kim, S., Rush, B. S., & Rice, T. R. (2020). A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-020-01542-3

Lifshitz, M., van Elk, M., & Luhrmann, T. M. (2019). Absorption and spiritual experience: A review of evidence and potential mechanisms. Consciousness and Cognition, 73, 102760. PubMed. https://doi.org/10.1016/j.concog.2019.05.008

Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. (2011). Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug Alcohol Depend, 114(1), 61–67. https://doi.org/10.1016/j.drugalcdep.2010.09.006

Madsen, M. K., Fisher, P. M., Stenbæk, D. S., Kristiansen, S., Burmester, D., Lehel, S., Páleníček, T., Kuchař, M., Svarer, C., Ozenne, B., & Knudsen, G. M. (2020). A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. European Neuropsychopharmacology, 33, 71–80. https://doi.org/10.1016/j.euroneuro.2020.02.001

Rodrı́guez, P., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., Sames, D., Scorza, C., & Carrera, I. (2020). A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.0c00152

Pribish, A., Wood, N., & Kalava, A. (2020). A review of nonanesthetic uses of ketamine. Anesthesiology Research and Practice, 2020, 5798285. https://doi.org/10.1155/2020/5798285

Halpern, J. H., Lerner, A. G., & Passie, T. (2018). A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Curr Top Behav Neurosci, 36, 333–360. https://doi.org/10.1007/7854_2016_457

Dakwar, E., Nunes, E. V., Hart, C. L., Hu, M. C., Foltin, R. W., & Levin, F. R. (2018). A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study. Neuropharmacology, 142, 270–276. https://doi.org/10.1016/j.neuropharm.2018.01.005

Dakwar, E., Levin, F., Hart, C. L., & al., et. (2020). A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized midazolam-controlled pilot trial. American Journal of Psychiatry, 177(2), 125–133. https://doi.org/10.1176/appi.ajp.2019.19070684

Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N. (2018). A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus. Frontiers in Molecular Neuroscience, 11(312). https://doi.org/10.3389/fnmol.2018.00312

Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., Šuláková, A., Jurok, R., Maryška, M., Kuchař, M., Páleníček, T., Riba, J., & Ramaekers, J. G. (2019). A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Psychopharmacology. https://doi.org/10.1007/s00213-019-05236-w

Sessa, B., Higbed, L., & Nutt, D. (2019). A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. Frontiers in Psychiatry, 10(138). https://doi.org/10.3389/fpsyt.2019.00138

Psychedelic Library

Numinous Ways Psychedelic Library

Bibliography

Find Us

More Info

Subscribe to Our Newsletter